Dr. Parul Shukla, a colon and rectal surgeon, told The Post that he always encourages his patients to commit to a colorectal ...

Medical experts emphasize that regular prostate screenings, particularly through rectal examinations, remain one of the most ...

The battle against rectal cancer has entered an extraordinary new phase with the advent of immunotherapy, offering hope to ...

Evidence continues to mount showing that eating red meat and drinking alcohol increase the risk of colorectal cancer.

Recent research from the S:CORT team has identified key biomarkers and treatment strategies that predict and enhance effectiveness of radiotherapy in rectal cancer treatment. Patients with ...

Rectal cancer is a cancer deriving from abnormal cell growth in the lining or epithelium of the rectum. Rectal and colorectal tumours are genetically considered to be the same cancer. Rectal ...

A CXB boost continues to provide an organ preservation benefit at 5 years, though there is some local regrowth after 3 years, researchers found.

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

The screenings for the fourth most common cause of cancer and cancer-related death in the Commonwealth will now be covered by health insurance.

Jemperli received FDA breakthrough therapy designation for locally advanced dMMR/MSI-H rectal cancer, following a Fast Track designation in January 2023. The designation aims to expedite development ...